Woodchucks were immunized with recombinant woodchuck hepatitis virus (WHV) core antigen (WHcAg) to investigate whether such immunization protects against WHV infection. The C gene was cloned into a pUC12 vector and expressed in Escherichia coll. Core particles purified by sucrose and CsC1 gradient centrifugation had a buoyant density of 1-37 g/ml which corresponded to the density of WHcAg particles present in chronically infected liver. Two animals immunized with the recombinant antigen developed high antibody titres and were protected against infection after challenge with WHV. The surface antigen (WHsAg) and WHV DNA were not detected in the sera of immunized animals after challenge and these animals did not develop anti-WHs. Three control animals developed a typical WHV infection. The protection from WHV infection may depend not on the presence of antibodies against the core protein but on a cellular immune response to WHcAg.
INTRODUCTION
Vaccination with hepatitis B virus (HBV) surface antigen (HBsAg) or woodchuck hepatitis virus (WHV) surface antigen (WHsAg) protects against HBV or WHV infection (Szmuness et al., 1981 ; Cote et al., 1986) . Antibodies against HBsAg (anti-HBs) neutralize HBV; this was shown by passive immunization with anti-HBs that could prevent infection after exposure to the virus (Beasley et al., 1983) . The core protein of HBV (HBcAg) is highly immunogenic producing good cellular and humoral immune responses (Milich & McLachlan, 1986; Milich et al., 1987a Milich et al., , 1988 . In addition HBcAg-primed T cells have a helper function, at least in humoral immune responses to envelope proteins of HBV after immunization with the complete virus (Milich et al., 1987 b) . In the natural course of HBV infection, a T cell response to the core protein follows immediately after a T cell response to preS2 and shortly after antibodies to HBcAg, i.e. anti-HBc of the IgM class can be detected (Vento et al., 1987) . Anti-HBc is always present at the onset of disease and reaches a high concentration in sera of patients chronically infected with HBV, but these antibodies do not protect. Anti-HBc passively transmitted to newborns from mothers who are chronic carriers of HBV do not protect these babies from HBV infection (Beasley et al., 1977) , indicating that these antibodies do not neutralize the virus. Murray et al. (1984 Murray et al. ( , 1987 and Iwarson et al. (1985) demonstrated that immunization of chimpanzees with the core protein of HBV provided complete or partial protection from HBV infection. In Iwarson's study, three chimpanzees were completely protected. After challenge with HBV, anti-HBc and antibody to e antigen (anti-HBe) titres increased, but only one animal seroconverted to anti-HBs. In Murray's studies, two of four immunized chimpanzees showed a low level of HBV replication after challenge; HBsAg was detectable in sera for 2 to 3 weeks and these chimpanzees later developed anti-HBs. At present it is not known what the requirements are for complete protection. The incomplete protection may be due to a low immune response in the animals vaccinated without adjuvant.
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This study was carried out to test whether immunization with WHcAg protects woodchucks from WHV infection. We used recombinant WHcAg instead of using the natural form from chronically infected liver. Recombinant WHc protein also assembles to form core particles similar to native core particles, which can be easily purified in large amounts. HBcAg has been shown to be highly immunogenic even without adjuvant (Iwarson et al., 1985) and might be used as an alternative vaccine against HBV infection e.g. in non-responders or low responders to HBsAg. We decided to use an immunization protocol with Freund's adjuvant to achieve a high immune response. Further studies will be carried out with other adjuvants which may be used in humans.
METHODS
Woodchucks. In 1985 a woodchuck colony was established in our laboratory, and breeding began in 1986. Three woodchucks included in our study (MW 301, female; MW 302, male; MW 303, male) were born in our colony at the Gesellschaft ffir Strahlen und Umweltforschung, Munich, F.R.G. At the beginning of the study, the animals were 10 months old. Two additional control animals (NW 518, NW 519) were trapped in New York State (North Eastern Wildlife, Ithaca, N.Y., U.S.A.).
Expression of WHc antigen in clone pUCWc-XP in Escherichia coll. The WHc gene without its preC region, derived from the clone PW8 (Ogston et al., 1982) was kindly provided by Dr J. Summers, Albuquerque, N.M., U.S.A. and was cloned into a pUC12 vector under the control ofa lacUV5 promoter. The WHo gene was cloned into pUC12 at its XholI site at nucleotide (nt) 2029 and at its PstI site at nt 3051 (Galibert et al., 1982) (Fig. 1) . The expressed product of clone pUCWc-XP has a deletion of three amino-terminal amino acids of the native WHo gene and contains nine additional amino acids derived from the//-galactosidase of the vector at its amino terminus. The carboxy terminus of WHcAg is complete. E. coil strain JM109 was transformed with the recombinant plasmid pUCWc-XP and 24 clones were tested by restriction analysis.
After induction of the WIle gene expression with 1 mM-isopropyl-~-D-thiogalactopyranoside (IPTG) for 2 h, bacteria in a 1 1 culture were pelleted, resuspended in 20 mM-Tris-HC1 pH 8.0 and incubated with 70 m~-EDTA and 5 mg/ml lysozyme for 30 min at 37°C. NP40 (0.2%) and NaCI to a final concentration of 150 mM were added and incubation was continued for 30 rain. After an ultrasonic treatment of 5 min, the lysate was centrifuged for I h, the supernatant was layered onto a two-step sucrose gradient (30 ~ and 15 % w/v) and centrifuged at 40 000 r.p.m. for 4 h in a TST 41.14 rotor (Kontron). The pellet was resuspended in CsCI (density 1.2 g/ml) and loaded onto a discontinuous CsC1 gradient (density 1.25 to 1.4 g/ml). After centrifugation for 70 h at 38 000 r.p.m, in a TST 41.14 rotor, 250 ~tl fractions were collected. The content of WHcAg was measured by a WHc-ELISA developed in our laboratory (see below).
Immunization protocols. Woodchucks MW 301 and MW 302 were each inoculated subcutaneously (s.c.) four times with 100 Ixg recombinant WHcAg emulsified in incomplete Freund's adjuvant at days 0, 20, 34 and 70, in four sites. Ten days after the last immunization these and control animals (MW 303, NW 518 and NW 519) were challenged intravenously (i.v.) with 20 I~1 WHV-positive woodchuck serum from a chronic carrier positive for WHsAg (titre 10 -3) and WHV DNA (10 s particles). After immunization and challenge, serum samples were taken weekly. To compare the immune response to WHcAg of woodchucks to that of other animals three rabbits were immunized four times [at day 1, day 14 and 43, s.c.; day 54, i.v.] at four sites with recombinant WHcAg (rabbit R 1, 10 Ixg/inoculation; rabbit R2, 5 l.tg/inoculation; rabbit R3, 100 ~tg/inoculation). After development of anti-WHo, rabbit R 1 was inoculated in addition with WHV-positive woodchuck serum, to investigate whether the amount of WHsAg in this inoculum could stimulate the production of anti-WHs. Serology WHsAg, WHcAg and anti-WHs were tested by ELISAs established in our laboratory (Schlipk6ter et al., 1989) . Anti-WHo was tested by a modified ELISA as described by Ponzetto et al. (1985) .
WHsAg ELISA. The wells of microtitre plates were coated with 50 p.1 of anti-WHs IgG (rabbit) diluted 400-fold in 0.1 M-carbonate buffer pH 9.4, and incubated overnight at 4 °C. Wells were washed three times with 0.05% Tween 20 in phosphate-buffered saline (PBS). To block non-specific reactions, 100 ~tl 1 ~ gelatine and 2 % negative woodchuck serum were added to the wells for 2 h at 37 °C. The wells were washed again and 50 ~tl of sera to be tested (10-fold dilution in PBS) were added and incubated at 37 °C for 2 h. Plates were washed again and incubated with peroxidase-labelled anti-WHs [100-fold dilution with 2~ negative woodchuck serum and 2~ bovine serum albumin (BSA)] at 37 °C for 2 h. After a final washing, 100 ttl of substrate (1 mg/ml o-phenylenediamine, 1 ttl/ml H202 in 0.1 M-phosphate buffer pH 6.0) was added for 15 min. The reaction was stopped with 100 ttl 0-5 M-H2SO4 and the absorbance was measured at 495 rim.
WHcAg ELISA. The wells of microtitre plates were coated with 50 Ixl of anti-WHc (IgG preparation of serum from a WHV carrier) at a 1000-fold dilution in 0.1 M-carbonate buffer, incubated overnight at 4 °C and washed with PBS-Tween 20. Blocking of excess binding sites was carried out as described above. After washing 50 txl aliquots of fractions to be tested for WHcAg were added in 100-fold dilutions and incubated at 37 °C for 4 h. After washing, 50 ~tl of peroxidase-tabelled anti-WHc was added and incubated at 37 °C for 2 h. After the final washing, the enzymic reaction was conducted as described above.
Anti-WHs and anti-WHc ELISA. The wells of microtitre plates were coated with 50 Ixl of anti-WHs or antiWHc as 800-fold or 1000-fold dilutions respectively, in 0.1 M-carbonate buffer pH 9-4, incubated overnight at 4 °C and washed with PBS-Tween 20. To block non-specific reactions, the wells were incubated with 100 I-d 1% BSA at 37 °C for 2 h as described above. After washing, 50 lal purified WHsAg (from sera) or WHcAg (from liver tissue) was added as 64-fold or 100-fold dilutions respectively and incubated at 37 °C for 4 h. The plates wer6 washed and incubated with 50 ~tl serum to be tested (10-fold dilution) at 37 °C for 2 h. After washing, 50 ~tl peroxidase-labelled anti-WHs or anti-Wile was added and incubated at 37 °C for 2 h. The anti-WHs serum was generated in rabbits by immunization with purified virions. This antibody detected predominantly WHsAg and showed a weak reaction with preS1 and preS2 by Western blotting. The anti-WHo IgG was prepared from a woodchuck which was a chronic carrier of WHV. After the final washing, the enzymic reaction was conducted as described above. The titre of sera was taken as the last dilution step giving an inhibition of 50%.
Western blot. E. coli containing a pUC12 plasmid and E. coli containing our recombinant clone pUCWc-XP were induced with IPTG, and the proteins were dissolved in sample buffer (39/0 sucrose, 2%/0 SDS, 59/0 fl-mercaptoethanol, 20 mM-Tris-HC1 pH 7.0, bromphenol blue), centrifuged, separated by 20% PAGE and transferred to nitrocellulose (Laemmli, 1970) . Saturation was done with 1% BSA in PBS for 6 h. The filters were incubated overnight with a rabbit antiserum to a fl-galactosidase-WHc fusion protein in PBS and 1% BSA. After washing with 0.1% NP40 in PBS for 1 h, the blots were saturated again with BSA and incubated with 12Si.labelled Protein A (Amersham) (1000-fold dilution in PBS and 19/0 BSA) for 3 h at room temperature. After washing and drying the blots were exposed on Amersham X-ray film for 8 h.
Spot hybridization of WHV DNA. DNA in the sera was assayed by spotting 5 ~tl serum on nitrocellulose, denaturing the DNA and hybridizing with 32p-labelled WHV DNA having a specific activity of approx. 5 x 108 c.p.m./~tg DNA (pW8 clone, a plasmid containing the entire WHV genome cloned at its unique EcoRI site in pHB20) (Maniatis et aL, 1982) .
Southern blot. Liver biopsies were assayed for WHV DNA which was extracted with NGM (4 M-guanidinum rhodanide, 0-5 M-fl-mercaptoethanol, 50 raM-sodium acetate, pH 5.5) and separated from RNA by centrifugation on a discontinous CsCI gradient (density of 1.8 to 1,5 g/ml). After digestion with proteinase K, DNA was extracted with phenol-chloroform and precipitated with ethanol. DNA (20 ~tg) was digested with EcoRI and electrophoresed on a 1 ~o agarose gel and transferred to a nylon membrane as described previously (Maniatis et al., 1982) . The hydbridization probe for detecting WHV DNA was prepared as above.
RESULTS
The WHc gene was cloned into a pUCl2 vector to express WHcAg in E. coli (Fig. 1) . This construct, which was called pUCWc-XP, expressed the WHc-gene as a ~-galactosidase fusion protein with nine additional heterologous amino acids. This construct eliminates major structural changes of WHcAg and probably allows the core particle to form. Fig. 2 shows a Western blot and silver staining of a lysate of IPTG-induced bacteria containing pUC 12 (lanes 1 and 3 respectively) and the same for a lysate of induced bacteria containing pUCWc-XP (lanes 2 and 4). Incubation of the blotted proteins with rabbit anti-WHc serum reveals a band of 22K expressed in the bacterial clone containing the plasmid pUCWc-XP. The expression of pUCWc-XP was found to be optimal after an induction time of 2 h. For purification of core proteins from E. coli, several different lysing solutions and purification methods (e.g. gel chromatography) were tested. However the best result was achieved by clearing the bacterial lysate by a low-speed centrifugation and loading the supernatant onto a sucrose gradient (15 and 30~o) as described above. After centrifugation, a significant amount of WHcAg was in the pellet which suggests that WHcAg forms a particle. These core particles were purified further by CsC1 gradient centrifugation, giving fractions which were tested by ELISA and Western blot analysis (Fig. 3) . The WHcAg particles from E. coli had a buoyant density of 1.37 g/ml, corresponding to the density of WHcAg particles analysed from chronically infected liver (data not shown). On the top of the gradient there was a second region of WHcAg activity, which may result from soluble WHcAg. The pure WHcAg-positive fractions were pooled (fractions 10 to 14) (Fig. 3) , dialysed and stored at -70 °C. The purity of WHcAg was determined by silver staining. A single band of 22K was visible after PAGE and silver staining (Fig. 3) , which accounts for 90 ~o of the absorption measured in a densitometer. In the last lane a Western blot of the pooled (Fig. 4) ; both animals developed anti-WHc after the first immunization. The serum sample drawn at day 20 after the first immunization had an anti-WHc titre of approx. 10 -3 in both animals; anti-WHc titres increased in M W 301 up to 10 -5 and in M W 302 to 10 -4, 8 days after the third immunization. These titres correspond to those of anti-W H c in chronic carrier woodchucks. The two immunized animals were challenged with 20 pl WHV-containing serum 10 days after the third booster. At the same time three control animals were infected with the same serum. No signs of W H V infection were found in the serum of the immunized animals and W H s A g ELISA and W H V D N A spot hybridization remained negative over 17 weeks. All control animals developed viraemia. (Fig. 4) . A biopsy taken at day 44 p.i. at the end of the viraemia of one control animal (WC 303) contained replicative forms of WHV DNA (Fig. 5) days after immunization. In order to investigate whether i.v. inoculation of WHV-positive serum in rabbits stimulates an anti-WHs response, we inoculated rabbit R1 with 20 ktl WHVpositive woodchuck serum. Neither WHsAg nor WHV DNA was detectable in the serum but anti-WHs was detected (titre of 10 -1) 3 weeks after inoculation of WHV.
DISCUSSION
In recent years the immune response to proteins of the nucleocapsid of different viruses have been studied in detail. Cytotoxic T cells against nucleoproteins have been identified, e.g. those of influenza A, human immunodeficiency and rabies viruses (McMichael et al., 1986; Walker et al., 1987; Celis et al., 1988) and they may be important in eliminating virus after infection. Cytotoxic T cells can destroy infected cells expressing viral proteins or short peptides on their cell membranes and the humoral response to envelope proteins then neutralize infectious free virus particles. Complete or partial protection from infection by immunization with core protein has been demonstrated for the rabies virus and HBV. In vaccination studies of rabies virus, it has also been shown that vaccination with the nucleocapsid alone protected against lethal peripheral challenge with homologous or heterologous virus strains (Dietzschold et al., 1987) ; this indicates that the core protein which has a more conserved amino acid sequence than envelope proteins of different strains may be important for vaccination against viruses with marked heterogenicity of envelope proteins (e.g. human immunodeficiency virus).
In our experiments we demonstrated WHV core protein immunogenicity which protects against challenge with WHV. Expression of WHc in E. coli yielded core proteins of WHV which formed core particles similar in density to core particles of chronically infected hepatocytes (M. Roggendorf, unpublished results). A similar assembly of HBV core particles has been described previously (Cohen & Richmond, 1982) . The core particles from E. coli were easy to purify and are highly immunogenic in rabbits and woodchucks. After one immunization with recombinant WHcAg, the sera of two animals (MW 301 and MW 302) had titres of 10 -3 which increased up to 10 -5 after three immunizations; comparable titres were obtained in rabbits. Similar titres of anti-WHc were found in chronic carriers of WHV. After challenge with WHV, neither of the two immunized woodchucks showed signs of WHV infection and produced no anti-WHs. We included a 'challenge' experiment with a rabbit primed with core proteins; this animal was found positive for anti-WHs, indicating that our test system is sensitive and that the woodchucks most probably did not produce anti-WHs. This interesting finding of possible WHc priming in rabbits will be followed in a separate study. Southern blotting of DNA extracted from biopsies at day 44 after challenge showed the absence of replicative forms of WHV DNA in the immunized animals. Three control animals developed typical WHV infections. The negative results of biopsies from the immunized animals does not competely exclude WHV replication, as it could have occurred at a low level in other parts of the liver.
Immunity to WHV infection independent of anti-WHs can be achieved by immunizing with WHcAg. There are two possible explanations for this protective effect. The first is that HBcAg/HBeAg-specific T helper cells can elicit anti-envelope antibodies that neutralize viruses (Milich et al., 1987 b) and this phenomenon could explain the ability of HBc or WHc vaccination to protect against HBV/WHV infection or at least against liver disease. Although our animals did not appear to develop anti-WHs, it is possible that our assay system is not sensitive enough to detect low levels of anti-WHs; in the studies by Iwarson et al. (1985) and Murray et al. (1984 Murray et al. ( , 1987 only three of seven animals seroconverted to anti-WHs after challenge. Another explanation which would need to be proved experimentally is that after immunization with WHcAg, T helper cell activity for cytotoxic T cell precursors is induced. After challenge with WHV some liver cells are infected and express complete core proteins or peptides on their membrane, as described for HBcAg (Uy et al., 1986; Sylvan et al., 1987; Kiyosawa et al., 1988) . Primed cytotoxic T cells may recognize these proteins and destroy infected hepatocytes or stop viral replication before maturation of the complete virus, which leads to infection of other hepatocytes. Cytotoxic T cells directed against core protein have been identified in patients with chronic hepatitis B (Mondelli et al., 1982; Eddleston et al., 1983; Naumov et al., 1984) . Both of these mechanisms may work together to eliminate WHV at an early phase after infection.
At present, studies are in progress to characterize cytotoxic T cell responses of woodchucks after immunization with core protein using vaccinia virus recombinants in an autologous system. This study was generously supported by the Deutsche Forschungsgemeinschaft (Ro 687/2-1).
